Milan, Italy

Loretta Lazzarato

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Rozzano, IT (2013)
  • Milan, IT (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Loretta Lazzarato: Innovator in Antitumor Compounds

Introduction

Loretta Lazzarato is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumor activity. With a total of 2 patents, her work focuses on innovative solutions for cancer treatment.

Latest Patents

Lazzarato's latest patents include "Water soluble furoxan derivatives having antitumor activity" and "Nitric oxide furoxan derivative compounds endowed with antitumoral activity." The first patent describes water-soluble compounds with a furoxan structure that inhibit metabolic pathways involved in tumor development. These compounds are also proposed for use as medicaments in tumor therapy and as adjuvants in immunotherapy protocols against neoplasms. The second patent relates to nitric oxide furoxan derivative compounds that have shown effectiveness in treating tumors and may serve as adjuvants in cancer immunotherapy.

Career Highlights

Throughout her career, Lazzarato has worked with notable organizations such as Humanitas Mirasole S.p.a. and Istituto Oncologico Veneto Irccs. Her research has been instrumental in advancing the understanding and treatment of cancer.

Collaborations

Lazzarato has collaborated with esteemed colleagues, including Antonella Viola and Enzo Bronte. These partnerships have contributed to her innovative research and the development of her patented compounds.

Conclusion

Loretta Lazzarato's work in developing antitumor compounds showcases her dedication to advancing cancer treatment. Her innovative patents and collaborations highlight her significant impact in the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…